Parvovirus B19-associated graft failure after allogeneic hematopoietic stem cell transplantation

Cancer Rep (Hoboken). 2022 Jan;5(1):e1403. doi: 10.1002/cnr2.1403. Epub 2021 May 1.

Abstract

Background: Parvovirus B19 (PVB19) infection has been implicated in allograft failure or dysfunction in solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the literature is limited.

Case: Two pediatric patients were diagnosed with PVB19 infection around the time of allo-HSCT graft failure. Both cases were secondary graft failure and required second allo-HSCT.

Conclusion: There are many risk factors and potential confounders in determining the exact etiology of graft failure after allo-HSCT. These two cases highlight the importance of including PVB19 in the diagnostic evaluation for graft failure. PVB19 infection may be an important risk factor for allo-HSCT graft failure.

Keywords: allogeneic hematopoietic stem cell transplantation; graft failure; parvovirus B19 infection.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Graft Rejection / etiology*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Infant
  • Male
  • Parvoviridae Infections / etiology*
  • Parvovirus B19, Human
  • Risk Factors